A Memphis, Tennessee hospital recently began using a first of its kind electric therapy treatment approved by the Food and Drug Administration (FDA) to treat the progression of mesothelioma, a rare and deadly form of lung cancer caused by exposure to asbestos fibers. “Because it is such a rare cancer, there has been little research opportunities to advance science and treatment of mesothelioma,” said Dr. Moon Fenton, West Cancer Center hematologist while speaking to local media.
For decades, doctors treated mesothelioma through a combination of surgery, radiation treatment, and chemotherapy. Now, doctors will have access to a fourth treatment option via the NovoTTF-100. The devices functions by attaching three to the front and back of the patient’s chest and sending electric fields into the body to target and disrupt mesothelioma cancer cells from growing and spreading, all while allowing healthy cells to remain intact.
“We are looking at 97% disease control at year one. So, patients who are using this technology in addition to the chemotherapy actually have stable disease or great response to treatment,” said Dr. Fenton in a local NBC interview. “This treatment is not invasive, and has minimal side effects.” Patient’s at Dr. Fenton’s hospital, West Cancer Center, will wear the device for 18 hours per day to treat mesothelioma.